Although TNF-R2 can be expressed on tumor cells, its main source may be highly suppressive regulatory T cells (Tregs) because the expansion of Tregs in cancer patients is followed by elevated serum values of soluble TNF-R2 (27), consistent with immune evasion. Here, TNFRSF1B is linked to neoplasm.